Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;28 Suppl 1(Suppl 1):e26449.
doi: 10.1002/jia2.26449.

Do we need a regulatory path for HIV post-exposure prophylaxis?

Veronica Miller  1 , Robin Schaefer  1
Affiliations

Do we need a regulatory path for HIV post-exposure prophylaxis?

Veronica Miller et al. J Int AIDS Soc. 2025 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The Forum for Collaborative Research receives unrestricted grants from the pharmaceutical industry, including from companies involved in the development of antiretroviral drugs (ViiV Healthcare, Merck and Gilead Sciences). These grants are provided to the organization and are not specifically linked to the present work. The authors (as individuals) have no relevant financial or non‐financial interests to disclose.

References

    1. Mayer KH, Allan‐Blitz L‐T. Post‐exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions. Lancet HIV. 2023;10(12):e816–e24. - PMC - PubMed
    1. Allan‐Blitz L‐T, Mayer KH. Updated guidelines on HIV post‐exposure prophylaxis: continued efforts towards increased accessibility. J Int AIDS Soc. 2024;27(11):e26393. - PMC - PubMed
    1. Oldenburg CE, Bärnighausen T, Harling G, Mimiaga MJ, Mayer KH. Adherence to post‐exposure prophylaxis for non‐forcible sexual exposure to HIV: a systematic review and meta‐analysis. AIDS Behav. 2014;18(2):217–25. - PMC - PubMed
    1. Chacko L, Ford N, Sbaiti M, Siddiqui R. Adherence to HIV post‐exposure prophylaxis in victims of sexual assault: a systematic review and meta‐analysis. Sex Transm Infect. 2012;88(5):335–41. - PubMed
    1. Beymer MR, Weiss RE, Bolan RK, Kofron RM, Flynn RP, Pieribone DL, et al. Differentiating nonoccupational postexposure prophylaxis seroconverters and non‐seroconverters in a community‐based clinic in Los Angeles, California. Open Forum Infect Dis. 2017;4(2):ofx061. - PMC - PubMed

LinkOut - more resources